A nine amino acid domain is essential for mutant prion protein toxicity

Journal of Neuroscience

Volumn 31, Issue 39, 2011, Pages 14005-14017

  Westergard, Laura ^a   Turnbaugh, Jessie A ^a,b   Harris, David A ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; MUTANT PROTEIN; PRION PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; ENDOCYTOSIS; MOLECULAR MECHANICS; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; CATTLE; CELL CULTURE TECHNIQUES; HEK293 CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION; OLIGOPEPTIDES; PROTEIN STRUCTURE, TERTIARY; PRPC PROTEINS; SHEEP; TURTLES; XENOPUS PROTEINS; ZEBRAFISH PROTEINS;

EID: 80053228890     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1243-11.2011     Document Type: Article

References (52)

1. Aguzzi A, Polymenidou M (2004) Mammalian prion biology: one century of evolving concepts. Cell 116:313-327.
2. Ashok A, Hegde RS (2009) Selective processing and metabolism of disease-causing mutant prion proteins. PLoS Pathog 5:e1000479.
3. Atarashi R, Nishida N, Shingematsu K, Goto S, Kondo T, Sakaguchi S, Katamine S (2003) Deletion of N-terminal residues 23-88 from prion prion protein (PrP) abrogates the potential to rescue PrP-deficient mice from PrP-like protein/doppel-induced neurodegeneration. J Biol Chem 278:28944-28949.
4. Baeuerle PA, Huttner WB (1986) Chlorate-a potent inhibitor of protein sulfation in intact cells. Biochem Biophys Res Commun 141: 870-877.
5. Baumann F, Tolnay M, Brabeck C, Pahnke J, Kloz U, Niemann HH, Heikenwalder M, Rülicke T, Bürkle A, Aguzzi A (2007) Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J 26:538-547.
6. Borchelt DR, Davis J, Fischer M, Lee MK, Slunt HH, Ratovitsky T, Regard J, Copeland NG, Jenkins NA, Sisodia SS, Price DL (1996) A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal 13:159-163.
7. Brimacombe DB, Bennett AD, Wusteman FS, Gill AC, Dann JC, Bostock CJ (1999) Characterization and polyanion-binding properties of purified recombinant prion protein. Biochem J 342:605-613.
8. Bü eler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C (1992) Normal development and behavior of mice lacking the neuronal cell-surface PrP protein. Nature 356:577-582.
9. Cardin AD, Weintraub HJ (1989) Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9:21-32.
10. Caughey B, Raymond GJ (1993) Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol 67:643-650.
11. Chen S, Yadav SP, Surewicz WK (2010) Interaction between human prion protein and A_ oligomers: the role of N-terminal residues. J Biol Chem 285:26377-26383.
12. Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, Autilio-Gambetti L (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270:19173-19180.
13. Chiesa R, Piccardo P, Ghetti B, Harris DA (1998) Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21:1339-1351.
14. Christensen HM, Harris DA (2009) A deleted prion protein that is neurotoxic in vivo is localized normally in cultured cells. J Neurochem 108:44-56.
15. Doh-ura K, Ishikawa K, Murakami-Kubo I, Sasaki K, Mohri S, Race R, Iwaki T (2004) Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models. J Virol 78:4999-5006.
16. Drisaldi B, Coomaraswamy J, Mastrangelo P, Strome B, Yang J, Watts JC, Chishti MA, Marvi M, Windl O, Ahrens R, Major F, Sy MS, Kretzschmar H, Fraser PE, Mount HT, WestawayD(2004) Genetic mapping of activity determinants within cellular prion proteins: N-terminal modules in PrPC offset pro-apoptotic activity of the Doppel helix B/B' region. J Biol Chem 279:55443-55454.
17. Fischer M, Rülicke T, Raeber A, Sailer A, Moser M, Oesch B, Brandner S, Aguzzi A, Weissmann C (1996) Prion protein (PrP) with aminoproximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 15:1255-1264.
18. Gu Y, Hinnerwisch J, Fredricks R, Kalepu S, Mishra RS, Singh N (2003) Identification of cryptic nuclear localization signals in the prion protein. Neurobiol Dis 12:133-149.
19. Hachiya NS, Watanabe K, Sakasegawa Y, Kaneko K (2004a) Microtubules-associated intracellular localization of the NH2-terminal cellular prion protein fragment. Biochem Biophys Res Commun 313:818-823.
20. Hachiya NS, Watanabe K, Yamada M, Sakasegawa Y, Kaneko K (2004b) Anterograde and retrograde intracellular trafficking of fluorescent cellular prion protein. Biochem Biophys Res Commun 315:802-807.
21. Harris DA, True HL (2006) New insights into prion structure and toxicity. Neuron 50:353-357.
22. Li A, Christensen HM, Stewart LR, Roth KA, Chiesa R, Harris DA (2007) Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125. EMBO J 26:548-558.
23. Mallucci G, Dickinson A, Linehan J, Klöhn PC, Brandner S, Collinge J (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 30: 871-874.
24. Mallucci GR, Ratté S, Asante EA, Linehan J, Gowland I, Jefferys JG, Collinge J (2002) Postnatal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 21:202-210.
25. Mallucci GR, White MD, Farmer M, Dickinson A, Khatun H, Powell AD, Brandner S, Jefferys JG, Collinge J (2007) Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prioninfected mice. Neuron 53:325-335.
26. Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J (1994) 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 8:121-127.
27. Massignan T, Stewart RS, Biasini E, Solomon IH, Bonetto V, Chiesa R, Harris DA (2010) A novel, drug-based, cellular assay for the activity of neurotoxic mutants of the prion protein. J Biol Chem 285: 7752-7765.
28. Nunziante M, Gilch S, Schatzl HM (2003) Essential role of the prion protein N terminus in subcellular trafficking and half-life of the cellular prion protein. J Biol Chem 278:3726-3734.
29. Ostapchenko VG, Makarava N, Savtchenko R, Baskakov IV (2008) The polybasic N-terminal region of the prion protein controls the physical properties of both the cellular and fibrillar forms of PrP. J Mol Biol 383: 1210-1224.
30. Pan T, Wong BS, Liu T, Li R, Petersen RB, Sy MS (2002) Cell-surfac e prion protein interacts with glycosaminoglycans. Biochem J 368: 81-90.
31. Parkin ET, Watt NT, Hussain I, Eckman EA, Eckman CB, Manson JC, Baybutt HN, Turner AJ, Hooper NM (2007) Cellular prion protein regulates β-secretase cleavage of the Alzheimer's amyloid precursor protein. Proc Natl Acad Sci U S A 104:11062-11067.
32. Pasupuleti M, Roupe M, Rydengård V, Surewicz K, Sunewicz WK, Chalupka A, Malmsten M, Särensen OE, Schmidtchen A (2009) Antimicrobial activity of human prion protein is mediated by its N-terminal region. PLoS One 4:e7358.
33. Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95:13363-13383.
34. Prusiner SB, ed (2004) Prion biology and diseases, Ed 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
35. Shmerling D, Hegyi I, Fischer M, Blättler T, Brandner S, Götz J, Rü licke T, Flechsig E, Cozzio A, von Mering C, Hangartner C, Aguzzi A, Weissmann C (1998) Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93:203-214.
36. Shyng SL, Huber MT, Harris DA (1993) A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J Biol Chem 268:15922-15928.
37. Shyng SL, Heuser JE, Harris DA (1994) Aglycolipid-anchored prion protein is endocytosed via clathrin-coated pits. J Cell Biol 125:1239-1250.
38. Shyng SL, Moulder KL, Lesko A, Harris DA (1995a) The N-terminal domain of a glycolipid-anchored prion protein is essential for its endocytosis via clathrin-coated pits. J Biol Chem 270:14793-14800.
39. Shyng SL, Lehmann S, Moulder KL, Harris DA (1995b) Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrP C, in cultured cells. J Biol Chem 270:30221-30229.
40. Solforosi L, Bellon A, Schaller M, Cruite JT, Abalos GC, Williamson RA (2007) Toward molecular dissection of PrPC-PrPSc interactions. J Biol Chem 282:7465-7471.
41. Solomon IH, Schepker JA, Harris DA (2010a) Prion neurotoxicity: insights from prion protein mutants. Curr Issues Mol Biol 12:51-61.
42. Solomon IH, Huettner JE, Harris DA (2010b) Neurotoxic mutants of the prion protein induce spontaneous ionic currents in cultured cells. J Biol Chem 285:26719-26726.
43. Solomon IH, Khatri N, Biasini E, Massignan T, Huettner JE, Harris DA (2011) An N-terminal polybasic domain and cell surface localization are required for mutant prion protein toxicity. J Biol Chem 286:14724-14736.
44. Sunyach C, Jen A, Deng J, Fitzgerald KT, Frobert Y, Grassi J, McCaffrey MW, Morris R (2003) The mechanism of internalization of glycosylphosphatidylinositol- anchored prion protein. EMBO J 22:3591-3601.
45. Supattapone S, Muramoto T, Legname G, Mehlhorn I, Cohen FE, DeArmond SJ, Prusiner SB, Scott MR (2001) Identification of two prion protein regions that modify scrapie incubation time. J Virol 75:1408-1413.
46. Taubner LM, Bienkiewicz EA, Copié V, Caughey B (2010) Structure of theflexible amino-terminal domain of prion protein bound to a sulfated glycan. J Mol Biol 395:475-490.
47. Taylor DR, Watt NT, Perera WS, Hooper NM (2005) Assigning functions to distinct regions of the N-terminus of the prion protein that are involved in its copper-stimulated, clathrin-dependent endocytosis. J Cell Sci 118:5141-5153.
48. Taylor DR, Whitehouse IJ, Hooper NM (2009) Glypican-1 mediates both prion protein lipid raft association and disease isoform formation. PLoS Pathog 5:e1000666.
49. Wadia JS, Schaller M, Williamson RA, Dowdy SF (2008) Pathologic prion protein infects cells by lipid-raft dependent macropinocytosis. PLoS One 3:e3314.
50. Warner RG, Hundt C, Weiss S, Turnbull JE (2002) Identification of the heparan sulfate binding sites in the cellular prion protein. J Biol Chem 277:18421-18430.
51. Yoshikawa D, Yamaguchi N, Ishibashi D, Yamanaka H, Okimura N, Yamaguchi Y, Mori T, Miyata H, Shigematsu K, Katamine S, Sakaguchi S (2008) Dominant-negative effects of the N-terminal half of prion protein on neurotoxicity of prion protein-like protein/doppel in mice. J Biol Chem 283:24202-24211.
52. Zulianello L, Kaneko K, Scott M, Erpel S, Han D, Cohen FE, Prusiner SB (2000) Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein. J Virol 74:4351-4360.